entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
283693,ACTG1P17,transcribed_pseudogene,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,4.47795540410312,-0.691781025192251,0.921590530480904,-0.750638165554139,0.452870445672472,0.961473650102656,NA
283693,ACTG1P17,transcribed_pseudogene,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,8.17550742148536,-0.721418767914398,0.654966003872267,-1.1014598676103,0.270696561889425,0.817218549776646,patient-derived GBM cell lines (PDGCLs)
283693,ACTG1P17,transcribed_pseudogene,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,7.63013710324338,-1.2896153039969,0.814204213123139,-1.58389662348979,0.113217245899523,0.374809215250549,A549
283693,ACTG1P17,transcribed_pseudogene,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,4.28172992559734,-0.257956055303813,1.04275861089417,-0.247378494513332,0.804615315959519,0.986418245486816,A549
283693,ACTG1P17,transcribed_pseudogene,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,6.14957657451281,-0.655357460842377,1.23882121818765,-0.529016980998387,0.59679367017232,0.904710881321044,A549
283693,ACTG1P17,transcribed_pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,2.40860119889941,-1.56687626519682,1.32664081032419,-1.18108553046391,0.237568747444613,1,sigmoid colon organoid
283693,ACTG1P17,transcribed_pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,2.40860119889941,-1.35738005403942,1.29547789692247,-1.04778325995681,0.294738476836897,1,sigmoid colon organoid
